This study aimed to (1) provide an up-to-date literature analysis evaluating the efficacy and safety of individual regimens for brain-metastatic EGFR-mutant NSCLC patients and (2) provide more prognostic information about brain-metastatic NSCLC patients based on data from large-population registries. Here, EGFR is linked to non-small cell lung carcinoma.